| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/11/2003 | WO2003102126A1 A method of cell therapy using fused cell hybrids |
| 12/11/2003 | WO2003102125A1 Electrofusion of cells and apparatus therefore |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003101586A1 Cell recovery |
| 12/11/2003 | WO2003101472A1 Dioxin elimination promoter |
| 12/11/2003 | WO2003101471A1 Calcium-containing composition from bone tissue |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101399A2 Novel bacterium for treatment of disease |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101389A2 Relief of aids symptoms |
| 12/11/2003 | WO2003101387A2 Globulin protein to lower cholesterol in humans |
| 12/11/2003 | WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 12/11/2003 | WO2003101201A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | WO2003101187A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | WO2003080823A3 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 12/11/2003 | WO2003078597A9 Tissue engineering |
| 12/11/2003 | WO2003078588A9 Primitive and proximal hepatic stem cells |
| 12/11/2003 | WO2003074568A9 Individualized anti-cancer antibodies |
| 12/11/2003 | WO2003072707B1 Compositions comprising reproductive cell media and methods for using such compositions |
| 12/11/2003 | WO2003052084A3 Cell constructs cultured in vitro, preparation and uses |
| 12/11/2003 | WO2003038063A3 Human secreted proteins |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003026580A3 Interactive therapeutic enclosures |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2002101056A3 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002060928A3 Medane genes and proteins |
| 12/11/2003 | US20030229908 Generating isogenic progenitor cells using nuclear transfer into enucleated oocytes for use as gene therapeutic tool in the treatment of cancer, muscular, nervous system, autoimmune and bone disorders; enzyme inhibitors; antiapoptosis |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229335 Infection therapy; sustained release |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 12/11/2003 | US20030229039 Gene therapy; mutant Dna |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030229008 Regenerating organs; anticancer agents; autoimmune disease; stabilization cells |
| 12/11/2003 | US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 12/11/2003 | US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents |
| 12/11/2003 | US20030228375 Extract of deer antlers; adjust testosterone concentration; sexual disorders |
| 12/11/2003 | US20030228372 Animal extract in cyclodextrin matrix; antiaging agents, immunology response |
| 12/11/2003 | US20030228371 Anti-infarction molecules |
| 12/11/2003 | US20030228329 Genetic engineering; insertion of gene; generating immunology response |
| 12/11/2003 | US20030228297 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 12/11/2003 | US20030228292 Methods of inducing or enhancing connective tissue repair |
| 12/11/2003 | US20030228289 Universal chimera bank |
| 12/11/2003 | US20030228288 Volume maintaining osteoinductive/osteoconductive compositions |
| 12/11/2003 | US20030228286 Therapy for degradation diseases; skin disorders; biodegradation matrix containing autologous cells; filling defects |
| 12/11/2003 | US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders |
| 12/11/2003 | US20030228281 Use of mutant herpes viruses and anticancer agents in the treatment of cancer |
| 12/11/2003 | CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | CA2488281A1 Novel bacterium for treatment of disease |
| 12/11/2003 | CA2488013A1 Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 12/11/2003 | CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | CA2487410A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | CA2487094A1 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells |
| 12/11/2003 | CA2487024A1 Control sequences of the human corin gene |
| 12/11/2003 | CA2486548A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | CA2485862A1 Expansion and transdifferentiation of human acinar cells |
| 12/11/2003 | CA2484629A1 Electrofusion of cells and apparatus therefore |
| 12/11/2003 | CA2484627A1 Cell recovery |
| 12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/10/2003 | EP1369122A1 Anticancer agent |
| 12/10/2003 | EP1368477A1 Vaccine |
| 12/10/2003 | EP1368473A2 Neurotransmission-associated proteins |
| 12/10/2003 | EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 12/10/2003 | EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 12/10/2003 | EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 12/10/2003 | EP1368419A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 12/10/2003 | EP1368238A1 Albumin in a flexible polymeric container |
| 12/10/2003 | EP1368062A2 Composition and method |
| 12/10/2003 | EP1368044A2 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection |
| 12/10/2003 | EP1368043A1 Blood brain barrier modulation using stressed autologous blood cells |
| 12/10/2003 | EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases |
| 12/10/2003 | EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 12/10/2003 | EP1367982A2 Hair follicle neogenesis by injection of follicle progenitor cells |
| 12/10/2003 | EP1367961A2 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 12/10/2003 | EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/10/2003 | EP1367892A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| 12/10/2003 | EP1148897B1 Methods and compositions for healing and repair of articular cartilage |
| 12/10/2003 | EP1115432B1 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge |
| 12/10/2003 | EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 12/10/2003 | EP0680316B1 Novel parasitic helminth proteins |
| 12/10/2003 | EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene |
| 12/10/2003 | EP0671924B1 Digitalis-like compounds |
| 12/10/2003 | CN1461343A 多核苷酸 Polynucleotide |
| 12/10/2003 | CN1461340A Method of isolating bipotent hepatic progenitor cells |
| 12/10/2003 | CN1461220A Vascularised tissue graft |
| 12/10/2003 | CN1460514A Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS |
| 12/10/2003 | CN1460510A Chinese patent medicine with the functions of replenishing qi and blood and nourishing the heart to calm the mind, its preparation method and quality control method |
| 12/10/2003 | CN1460509A Chinese patent medicine for curing cardiovascular disease, its preparation method and quality control method |
| 12/10/2003 | CN1460498A Bone-strengthening medicine, tablet, capsule and oral liquor and preparation method thereof |
| 12/10/2003 | CN1460496A Medicine for curing cardiac premature beat |
| 12/10/2003 | CN1460487A Propolis soft capsule and its preparation method |
| 12/10/2003 | CN1460486A Propolis honey sweets and preparation process |
| 12/10/2003 | CN1130227C Viral agent associated with mystery swine disease |
| 12/10/2003 | CN1130220C Chinese medicine 'Ershefengshiwan' |
| 12/10/2003 | CN1130219C Powder for curing hepatic calculus |
| 12/10/2003 | CN1130217C Medicine for preventing and treating cancer and preparing method thereof |
| 12/10/2003 | CN1130216C Medicine for preventing and treating radiation damage of central nervous system |
| 12/10/2003 | CN1130215C Medicine for curing immunologic disease |